clinicaltrials gov 5 amino 1mq 5-Amino-1MQ Peptide Dosing Guide: Oral Protocol, Reconstitution & Safety (2026) 5-Amino-1MQ Research Material | Modern

Well use your responses to deliver personalized recommendations tailored to your needs

Based on preclinical (animal and cellular) data only, inhibition of NNMT by 5-Amino-1MQ is theorised to: Raise intracellular NAD+ levels Activate SIRT1 and other sirtuins (proteins linked to metabolic regulation) Reduce fat cell (adipocyte) size and proliferation Improve insulin sensitivity These effects have been demonstrated in mouse models (Neelakantan et al., 2019), but robust human clinical trial data are currently absent

Full evaluation requires at least six months of consistent use

Piedra-Quintero ZL, Wilson Z, Nava P, Guerau-de-Arellano M

As cells age, mitochondria can become less efficient, leading to a decline in overall cellular function